| Schizophrenia |
1 |
0.79 |
| Weight Management |
0 |
0.79 |
| Weight Gain |
0 |
0.68 |
| Antipsychotics |
0 |
0.56 |
| Clinical Guidelines |
0 |
0.36 |
| Depression |
0 |
0.23 |
| Metabolic Syndrome |
0 |
0.21 |
| Metabolism |
0 |
0.16 |
| Kidney |
0 |
0.12 |
| Bipolar Disorder |
0 |
0.11 |
| Addiction |
0 |
0.09 |
| Alcoholism |
0 |
0.09 |
| Cyclic Antidepressants |
0 |
0.09 |
| Adherence |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Obesity |
0 |
0.08 |
| Alcohol Abuse |
0 |
0.06 |
| Lactic Acidosis |
0 |
0.06 |
| Abuse |
0 |
0.04 |
| Acidosis |
0 |
0.04 |
| Adverse Effects |
0 |
0.04 |
| Antidepressant drug |
0 |
0.04 |
| Anxiety |
0 |
0.04 |
| Anxiety Disorder |
0 |
0.04 |
| Complementary and Alternative Medicine |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Geriatrics |
0 |
0.04 |
| Major Depression |
0 |
0.04 |
| Meta-Analysis |
0 |
0.04 |
| Multidisciplinary Team |
0 |
0.04 |
| Nonpharmacologic |
0 |
0.04 |
| Patient History |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Psychopharmacology |
0 |
0.04 |
| Psychosis |
0 |
0.04 |
| Psychotropic Drugs |
0 |
0.04 |
| Vitamin |
0 |
0.04 |